Black Rock Inc. A Tyr Pharma Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,392,074 shares of LIFE stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,392,074

Previous 1,364,880 1.99%

Holding current value

$2.59 Million

Previous $2.66 Million 18.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.0 - $2.07 $0 - $56,291	27,194 Added 1.99%	1,392,074 $2.17 Million
Q1 2024 May 10, 2024	BUY	$1.42 - $2.02 $3,578 - $5,090	2,520 Added 0.18%	1,364,880 $2.66 Million
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.51 $5,391 - $7,334	4,857 Added 0.36%	1,362,360 $1.92 Million
Q3 2023 Nov 13, 2023	SELL	$1.55 - $2.23 $19,616 - $28,222	-12,656 Reduced 0.92%	1,357,503 $2.14 Million
Q2 2023 Aug 11, 2023	BUY	$1.72 - $2.57 $1.79 Million - $2.68 Million	1,040,982 Added 316.24%	1,370,159 $2.96 Million
Q1 2023 May 12, 2023	BUY	$1.88 - $2.5 $113,234 - $150,577	60,231 Added 22.4%	329,177 $691,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $2.49 $3,732 - $4,601	1,848 Added 0.69%	268,946 $588,000
Q3 2022 Nov 14, 2022	SELL	$2.79 - $4.15 $8,534 - $12,694	-3,059 Reduced 1.13%	267,098 $801,000
Q2 2022 Aug 12, 2022	SELL	$2.63 - $5.61 $15,785 - $33,671	-6,002 Reduced 2.17%	270,157 $765,000
Q1 2022 May 12, 2022	BUY	$4.75 - $7.54 $3,705 - $5,881	780 Added 0.28%	276,159 $1.48 Million
Q4 2021 Feb 10, 2022	BUY	$7.29 - $9.5 $425,495 - $554,486	58,367 Added 26.9%	275,379 $2.06 Million
Q3 2021 Nov 09, 2021	SELL	$4.22 - $12.48 $33,190 - $98,155	-7,865 Reduced 3.5%	217,012 $1.97 Million
Q2 2021 Aug 11, 2021	BUY	$3.62 - $4.88 $814,054 - $1.1 Million	224,877 New	224,877 $1.1 Million

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account